- Hemimasticatory Spasm Treated With Muscle Afferent Block Therapy and Occlusal Splint
-
Yoshida K
- KMID: 2554701
- J Mov Disord.
- 2024 Apr;17(2):230-232.
- doi: 10.14802/jmd.23249
-
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease
-
Mishra T, Kamble N, Bhattacharya A, Yadav R, Srinivas D, Pal PK
- KMID: 2554706
- J Mov Disord.
- 2024 Apr;17(2):245-247.
- doi: 10.14802/jmd.23247
-
- CITED
-
- Close
- SHARE
-
- Close
- A Rare Case of Uner Tan Syndrome With Incidentally Detected Choroid Plexus Papilloma
-
Chakraborty U, Mukherjee A, Datta AK, Biswas A, Gangopadhyay G
- KMID: 2554699
- J Mov Disord.
- 2024 Apr;17(2):223-225.
- doi: 10.14802/jmd.23192
-
- CITED
-
- Close
- SHARE
-
- Close
- Cough as a presenting symptom in Wilson’s Disease
-
Phua CS, Bhaskar S, Bertram K
- KMID: 2554697
- J Mov Disord.
- 2024 Apr;17(2):218-219.
- doi: 10.14802/jmd.23221
-
- CITED
-
- Close
- SHARE
-
- Close
- Comments on “Absence of Alpha-Synuclein Aggregation in Patients With Parkinson’s Disease Complicated by Sigmoid Volvulus”
-
Atamanalp SS, Atamanalp RS
- KMID: 2554707
- J Mov Disord.
- 2024 Apr;17(2):248-249.
- doi: 10.14802/jmd.24078
-
- CITED
-
- Close
- SHARE
-
- Close
- The First Indian Patient With Benign Hereditary Chorea due to a De Novo Mutation in the NKX2-1 Gene
-
Garg D, Agarwal A, Faruq M, Srivastava AK
- KMID: 2554704
- J Mov Disord.
- 2024 Apr;17(2):239-241.
- doi: 10.14802/jmd.23273
-
- CITED
-
- Close
- SHARE
-
- Close
- Meige Syndrome as a Craniofacial Type of Dystonia Treatable by Dual Dopaminergic Modulation Using L-DOPA/Chlorpromazine: A Case Report
-
Matsumoto S, Goto S
- KMID: 2554702
- J Mov Disord.
- 2024 Apr;17(2):233-235.
- doi: 10.14802/jmd.23265
-
- CITED
-
- Close
- SHARE
-
- Close
- Genetically Proven Ataxia With Vitamin E Deficiency With Predominant Cervicobrachial Dystonic Presentation: A Case Report From India
-
Holla VV, Gurram S, Kamath SD, Arunachal G, Kamble N, Yadav R, Pal PK
- KMID: 2554698
- J Mov Disord.
- 2024 Apr;17(2):220-222.
- doi: 10.14802/jmd.23227
-
- CITED
-
- Close
- SHARE
-
- Close
- A Practical Guide for Clinical Approach to Patients With Huntington’s Disease in Korea
-
Shin C, Kim R, Yoo D, Oh E, Moon J, Kim M, Lee JY, Kim JM, Koh SB, Kim M, Jeon B, on behalf of the Korean Huntington’s Disease Society
- KMID: 2554688
- J Mov Disord.
- 2024 Apr;17(2):138-149.
- doi: 10.14802/jmd.24040
-
- CITED
-
- Close
- SHARE
-
- Close
- Suprahyoid Tremor as an Early Feature of Multiple System Atrophy-Parkinsonism: A Case Report
-
Bhattacharjee S, Aggarwal R, Macdonagh R, Kobylecki C
- KMID: 2554705
- J Mov Disord.
- 2024 Apr;17(2):242-244.
- doi: 10.14802/jmd.23261
-
- CITED
-
- Close
- SHARE
-
- Close
- Basal Ganglia Syndrome in a Male With an XK Gene Variant but Without XK Disease (McLeod Syndrome)
-
Yu JRT, Walker RH, Danek A, Westhoff CM, Vege S, Itin I
- KMID: 2554700
- J Mov Disord.
- 2024 Apr;17(2):226-229.
- doi: 10.14802/jmd.23196
-
- CITED
-
- Close
- SHARE
-
- Close
- α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders
-
Hatano T, Okuzumi A, Matsumoto G, Tsunemi T, Hattori N
- KMID: 2554687
- J Mov Disord.
- 2024 Apr;17(2):127-137.
- doi: 10.14802/jmd.24075
Mutations in the SNCA gene, which encodes α-synuclein (α-syn), play a key role in the development of genetic Parkinson’s disease (PD). α-Syn is a major component of Lewy bodies in... -
- CITED
-
- Close
- SHARE
-
- Close
- Accessibility of Device-Aided Therapies for Persons With Parkinson’s Disease in Poland
-
Smilowska K, Pietrzykowski T, Chaudhuri KR, Bloem BR, Wamelen DJv
- KMID: 2554695
- J Mov Disord.
- 2024 Apr;17(2):208-212.
- doi: 10.14802/jmd.23172
Objective Access to care for people with Parkinson’s disease (PD), particularly to device-aided therapies (DAT), is not equally distributed. The objective was to analyze accessibility to DAT (deep brain stimulation,... -
- CITED
-
- Close
- SHARE
-
- Close
- Loss-of-Function Variant in the SMPD1 Gene in Progressive Supranuclear Palsy-Richardson Syndrome Patients of Chinese Ancestry
-
Lim SY, Tan AH, Foo JN, Tan YJ, Chew EG, Annuar AA, Closas AMD, Pajo A, Lim JL, Tay YW, Nadhirah A, Hor JW, Toh TS, Lit LC, Zulkefli J, Ngim SJ, Lim WK, Morris HR, Tan EK, Ng AS
- KMID: 2554696
- J Mov Disord.
- 2024 Apr;17(2):213-217.
- doi: 10.14802/jmd.24009
Lysosomal dysfunction plays an important role in neurodegenerative diseases, including Parkinson’s disease (PD) and possibly Parkinson-plus syndromes such as progressive supranuclear palsy (PSP). This role is exemplified by the involvement... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of 18p Chromosomal Deletion Encompassing GNAL in a Patient With Dystonia-Parkinsonism
-
Di Rauso G, Cavallieri F, Monfrini E, Fraternali A, Fioravanti V, Grisanti S, Gessani A, Campanini I, Merlo A, Toschi G, Napoli M, Pascarella R, Silipigni R, Finelli P, Paul JJ, Bauer P, Versari A, Di Fonzo A, Valzania F
- KMID: 2554703
- J Mov Disord.
- 2024 Apr;17(2):236-238.
- doi: 10.14802/jmd.23222
-
- CITED
-
- Close
- SHARE
-
- Close
- Extraction of the pull force from inertial sensors during the pull test for Parkinson’s disease: A reliability study
-
Taniuchi R, Kanai S, Hara A, Monden K, Nagatani H, Torii T, Harada T
- KMID: 2554689
- J Mov Disord.
- 2024 Apr;17(2):150-157.
- doi: 10.14802/jmd.23185
Objective To examine the inter- and intra-rater reliability of the pull test in patients with Parkinson’s disease (PD) using the extracted pull force. Methods In this inter- and intra-rater reliability study,... -
- CITED
-
- Close
- SHARE
-
- Close
- Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect
-
Nasri A, Sghaier I, Neji A, Gharbi A, Abida Y, Mrabet S, Gargouri A, Djebara MB, Kacem I, Gouider R
- KMID: 2554690
- J Mov Disord.
- 2024 Apr;17(2):158-170.
- doi: 10.14802/jmd.23178
Objective Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder encompassing several phenotypes with various motor and cognitive deficits. We aimed to study motor and cognitive characteristics across PSP phenotypes... -
- CITED
-
- Close
- SHARE
-
- Close
- Fasting Plasma Glucose Levels and Longitudinal Motor and Cognitive Outcomes in Parkinson’s Disease Patients
-
Choi KE, Ryu DW, Oh YS, Kim JS
- KMID: 2554694
- J Mov Disord.
- 2024 Apr;17(2):198-207.
- doi: 10.14802/jmd.23264
Objective Hyperglycemia and diabetes mellitus have been identified as poor prognostic factors for motor and nonmotor outcomes in patients with Parkinson’s disease (PD), although there is some controversy with this... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Live-Streaming Tele-Exercise Intervention in Patients With Parkinson’s Disease: A Pilot Study
-
Ha J, Park JH, Lee JS, Kim HY, Song JO, Yoo J, Ahn JH, Youn J, Cho JW
- KMID: 2554693
- J Mov Disord.
- 2024 Apr;17(2):189-197.
- doi: 10.14802/jmd.23251
Objective Exercise can improve both motor and nonmotor symptoms in people with Parkinson’s disease (PwP), but there is an unmet need for accessible and sustainable exercise options. This study aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- High Levels of Mutant Huntingtin Protein in Tear Fluid From Huntington’s Disease Gene Expansion Carriers
-
Gijs M, Jorna N, Datson N, Beekman C, Dansokho C, Weiss A, Linden DEJ, Oosterloo M
- KMID: 2554692
- J Mov Disord.
- 2024 Apr;17(2):181-188.
- doi: 10.14802/jmd.24014
Objective Huntington’s disease (HD) is an autosomal dominant, fully penetrant, neurodegenerative disease that most commonly affects middle-aged adults. HD is caused by a CAG repeat expansion in the HTT gene,... -
- CITED
-
- Close
- SHARE
-
- Close
